Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10550006 | Journal of Chromatography B | 2011 | 4 Pages |
Abstract
A new method of analysis has been developed and validated for the determination of firocoxib, a new nonsteroidal anti-inflammatory drug (NSAID) approved for use in horses and dogs to control pain and inflammation associated with osteoarthritis. Following a liquid extraction using ethyl acetate:hexane (40:60), samples were separated by isocratic reversed-phase HPLC on a Sunfire C18 column and quantified using UV detection at 290Â nm. The mobile phase was a mixture of water with 0.025% trifluoroacetic acid and acetonitrile, with a flow-rate of 1.1Â ml/min. The procedure produced a linear curve over the concentration range 5-1500Â ng/ml with a lower limit of quantification of 5Â ng/ml. Intra- and inter-assay variability was less than 7%. The average recovery was 98%. The method is suitable for the analysis of clinical samples from pharmacokinetic studies and can also be used for small volume sample sizes.
Related Topics
Physical Sciences and Engineering
Chemistry
Analytical Chemistry
Authors
S. Cox, J. Yarbrough,